Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.
| Metric | ZOREN | NRGV | STEM | FLNC | BLX | SLR | Ind. Median |
|---|---|---|---|---|---|---|---|
| P/E | — | — | 0.46● | — | — | 15.14 | 18.11 |
| P/B | 0.22 | 22.80 | -0.25● | 6.10 | 2.50 | 3.25 | 1.29 |
| EV/EBITDA | 8.70 | — | 1.64● | — | 14.99 | 13.11 | 11.95 |
| P/S | 0.38● | 3.20 | 0.44 | 0.87 | 4.24 | 8.47 | 2.91 |
| Metric | ZOREN | NRGV | STEM | FLNC | BLX | SLR | Ind. Median |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.93 | 1.44● | 0.84 | 1.43 | 1.24 | 0.59 | 1.07 |
| Debt/Equity | 96.3% | 570.5% | -123.6%● | 109.2% | 310.0% | 205.8% | 51.3% |
| NetDebt/EBITDA | 6.98 | -1.21● | 1.33 | 1.01 | 7.98 | 4.94 | 3.22 |
| Metric | ZOREN | GWIND | TATEN | AYDEM | AYEN | BIOEN | Ind. Median |
|---|---|---|---|---|---|---|---|
| P/E | — | 15.56● | 63.18 | — | 36.49 | — | 18.11 |
| P/B | 0.22● | 0.87 | 1.72 | 0.45 | 0.50 | 2.86 | 1.29 |
| EV/EBITDA | 8.70 | 5.92● | 12.78 | 7.61 | 6.76 | 57.23 | 11.95 |
| P/S | 0.38● | 4.43 | 5.00 | 1.39 | 1.23 | 3.10 | 2.91 |
| Metric | ZOREN | GWIND | TATEN | AYDEM | AYEN | BIOEN | Ind. Median |
|---|---|---|---|---|---|---|---|
| Current Ratio | 0.93 | 2.07● | 0.52 | 1.27 | 0.78 | 0.37 | 1.07 |
| Debt/Equity | 96.3% | 20.8%● | 87.5% | 57.3% | 36.2% | 179.1% | 51.3% |
| NetDebt/EBITDA | 6.98 | 0.62● | 4.20 | 4.16 | 2.68 | 21.71 | 3.22 |
The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.
Data on this page refreshes once per day. Price data as of Jul 3, 26. This content is for informational purposes only and is not investment advice.